Amylyx class action Relyvrio, page-8

Hi Theoc,

Its so hard to value PAA.


Nowhere in the World does any small or BP have 80 conditions that they can treat.

To my knowledge we are absolutely unique.

Whoever buys this will end up with a plethora of varied conditions with a patent runway to 2038, along with a ODD..

Potential is massive and what a bonanza for the prospective patients.

Remember amongst Australian Pharmaceutical Companies we rank number 4 for patents.

The benefits

1. Protection of technology investment
2. Reduced risk of litigation
3. Higher royalties
4. Access to competitors technology through cross licensing
5. Wider market reach and revenue generation
6. Controlled development and deployment of technology.

I mean what's the value on Kirribilli House ?

Kpax